Abstract: Host-defense antimicrobial peptides (AMPs) are a promising lead in the search for novel antibiotics. Many of these peptides exhibit broad-spectrum antibacterial ability, low toxicity toward human cells, and little susceptibility to induction of bacterial resistance. Our research focuses on the development of synthetic polymers that are able to mimic the amphiphilic and cation-rich characteristics of AMPs. This derives bioactive polymers that retain the activity profile of AMPs while utilizing a construct that is less expensive and easier to produce and manipulate chemically. This review details structure-activity relationships (SARs) of a new class of arginine-rich, synthetic AMP mimicking polymers (SAMPs), the guanylated polymethacrylates. These are contrasted with those of amine-based polymers that are mimics of lysine-rich AMPs. The ideal composition for candidates for practical applications was identified as those containing guanidines as a cation source, having a low molecular weight and a low level of lipophilicity. This gave polymers with high potency against Gram-positive strains of bacteria (e.g., Staphylococcus epidermidis MIC = 10 μg/mL) and low toxicity towards human red blood cells ( < 4 % hemolysis at given MIC). This work emphasizes the need to rationalize observed biological activities based not purely on the global lipophilic and cationic character of polymers but rather to consider the profound effect that specific pendant functional groups may have on the potency, selectivity, and mechanisms behind the action of antimicrobial polymers.
Introduction

Antimicrobial peptides
With the increasing appearance of resistant strains of bacteria in clinical practice comes the major concern that a number of common antibiotics may lose their therapeutic efficacy in the near future. Classical antibiotics such as penicillin achieve their effects through binding to discrete protein targets. Particularly if sub-optimal levels are used during treatment, this mode of action can lead to genetic acquisition of bacterial resistance through mechanisms such as enzymatic deactivation or protein target modification [1] . There is hence an urgent need to develop novel and effective antibacterial agents with a reduced susceptibility to the induction of resistance.
Host defense antimicrobial peptides (AMPs) have been hailed as a promising lead in this area. These peptides are naturally produced by organisms as part of their innate defense system to ward off invading microbes. Many have been shown to have broad spectrum antimicrobial activity with low toxicity towards mammalian cells, and, importantly, they have also shown reduced susceptibility to the development of resistance. This is thought to be due to their more generalized mechanism of action whereby their constituent high concentration of cationic amino acids (lysine and arginine) drives an electrostatic attraction to the negatively charged phosphate head groups present on bacterial membranes (Fig. 1) [2] . Herein also lies the key to the selectivity of AMPs, since mammalian cells typically have a net neutral charge at the cell surface, thereby avoiding the electrostatic targeting of these cells. Following initial binding of the AMP to the surface of the bacteria, it is thought that the lipophilic component of the peptide interacts with the cellular membrane causing permeabilization, eventually leading to cell-death. The development of microbial resistance to an AMP would therefore require changing the entire membrane composition or organization [3] . Pathways involving deactivation of AMPs would also be fairly difficult as they vary greatly in sequence and typically do not exhibit specific epitopes for protein recognition. Both are potential explanations for the reduced prevalence of bacterial resistance to AMPs compared with classical antibiotics.
While AMPs have displayed great promise for the development of a new generation of antimicrobial therapies, their transition from bench to bedside has been very limited. This can be explained through the fact that peptides show low pharmacokinetic and chemical stability and can be expensive to produce on large scale. The key to success thus seems to lie in the development of synthetic AMP analogues that are able overcome such limitations while retaining the structural properties essential for antimicrobial efficacy and tolerance by human tissue and cells.
Synthetic mimics of antimicrobial peptides
Several classes of AMP-mimicking polymers have been developed to overcome such issues. These polymers, constructed from appropriate monomers, have a repeating backbone structure with pendant functional groups which can be likened to that of a peptide with pendant amino acid side chains of the AMPs (Fig. 2) . These polymers are designed to suitably mimic the low molecular weight and amphiphilic nature of AMPs through selection of appropriate lipophilic and cationic monomers. Many classes currently exist, including the polynorbornenes [4] , polycarbonates [5] , polyanilines [6] and polymethacrylates [7, 8] , which upon suit- able optimization of cationic and lipophilic balance, retain the potent antimicrobial effects and low mammalian cell toxicity of the peptides. Their production is, however, more accessible and economically feasible when compared to natural AMPs. Furthermore, these synthetic polymers can be chemically modified via facile routes to access a broader range of chemical structures.
Guanylated polymethacrylates
To date, much of the work with antimicrobial polymers has focused on the use of primary amine and simple N-alkyl derivatives as the source of cationic charge. This is surprising given the high prevalence of AMPs containing substantial amounts of the amino acid arginine, which bears a pendant guanidine group that is positively charged at the pH typical of buffered mammalian body fluids. Moreover, many studies suggest that high arginine content can be correlated with strong bacterial cell-lytic behavior [9] [10] [11] [12] [13] and that arginine-rich AMPs can function as more effective antimicrobials than equivalent lysine-rich peptides [14] . This may be explained by the fact that a guanidine group is capable of forming multidendate bonds with the anionic phosphate headgroups (Fig. 3) , yielding a stronger bacterial membrane interaction than amine groups. Furthermore, the higher pK a values of guanidines (e.g., pK a of arginine gunidinium group = 12.48) when compared with amines (e.g., pK a of lysine amino group = 10.53) would also mean that a higher proportion of guanidines would be charged at physiological pH, imparting a greater cationic character. A high concentration of guanidines can also assist with translocation across membranes [11, [15] [16] [17] thus underlying the fact that polyarginine functions as a cell-penetrating peptide [18] [19] [20] . As a result, a number of guanidine-based polymers and nanoparticles have been designed as potential drug delivery vehicles to facilitate the transport of drugs to intracellular targets [21] [22] [23] [24] .
Prior to our work, only one other group investigated the incorporation of guanidine based cations into antimicrobial polynorbornene polymers. Tew and colleagues found evidence that the replacement of the amine pendant groups of the inactive Poly-1 (Fig. 4) with guanidines, to give the corresponding PGON series, resulted in polymers with high antimicrobial activity and low toxicity [25] . To the best of our knowledge, however, no such work has previously been performed for other classes of antimicrobial polymer. Leading from this, our study took inspiration from arginine-rich AMPs and developed synthetic routes to a series of guanidine-based polymethacrylates [26] , as methacrylates have several advantages over other classes of polymers [27] . This body of work also served to establish aspects of the structure-activity relationships (SARs) for this novel class of antimicrobial polymers, such as the effect of molecular weight and lipophilicity, while making direct comparisons to amine-based species.
Results and discussion
Polymer design, synthesis and biological testing
Our work focused on the preparation of a series of guanidine based, amphiphilic polymethacrylates for antimicrobial and toxicological assessments [26] . To be able to establish the SARs for this new class, the series was designed to allow the systematic variation, and thus investigation, of various aspects of composition (e.g. molecular weight and lipophilic character) and their effect on activity and toxicity profiles. Also, to establish the importance of cation choice, it was necessary to be able to make direct comparisons between the novel guanidines and their amine equivalents while keeping other SAR aspects constant. The synthetic methods were hence designed to accommodate the discrete investigation of all three variables (molecular weight, lipophilicity and choice of cation).
Reversible addition-fragmentation chain transfer (RAFT) polymerization conditions were utilized to prepare a series of random copolymers of methylmethacrylate (MMA) and 2-aminoethyl methacrylate (AEMA) (PA1-8, Scheme 1) [26] . RAFT was selected for this work as it ensured the synthesis of well-defined polymers with narrow dispersities (Đ = 1.02-1.15, Table 1 ), allowing the unambiguous elucidation of molecular weight effects. Lipophilic character [molar percent methylmethacrylate (MP methyl )] was controlled via altering monomer feed ratios, and stretched from 0 % for the cationic homopolymer (PA6), up to the most lipophilic of the series with 63 % methyl content (PA5). Polymer chain length or degree of polymerization (DP) was altered via monomer to chain-transfer agent (CTA) ratios used during polymerization and yielded amine polymers that covered chain lengths from 20 (PA4) to 174 units (PA8).
To facilitate the direct comparison of the amine and guanidine series, a proportion of each of PA1 to 8 was directly converted into the corresponding guanidine PG1-8 polymer using base-catalysed guanylation conditions as described previously [26] (Scheme 2). This facile method avoids the problems associated with the direct synthesis of 2-guanidinoethyl methacrylate (2-GEMA) from the commercially available 2-aminoethylmethacrylate (2-AEMA). While 2-AEMA is known to rapidly isomerize under basic conditions, this occurs much less readily in the polymer form, [8, 28] thus allowing the successful post-polymerization formation of guanidine polymers directly from the amines in a single step. This gave two series that were closely approximated for chain length and lipophilic character, allowing the clear identification of the role that pendant guanidine groups would have on the activity profile of polymers. Thus, in a similar fashion to the amines, the guanidines covered a range of molecular weights (DP = 17-142) and lipophilicities (MP methyl = 0-64 %). The synthesized polymers were characterized using a combination of 1 H NMR, and SEC and the quantitative conversion of pendant amine groups to guanidines was confirmed using 1 H NMR, FT-IR and MALDI-ToF as previously described [29] . The final eight amine (PA1-8) and eight guanidine (PG1-8) polymers were subject to an extensive series of clinically relevant antibacterial [Staphylococcus epidermidis, methicilin-resistant Staphylococcus aureus (MRSA), Escherichia coli], antifungal (C. albicans), hemolytic and hemagglutination assessments using standard protocols [26] . For the purposes of this review, we will focus on the data obtained with a vigorous strain (ATCC 35984) of the Gram-positive bacterium S. epidermidis, as this forms the most complete data set obtained. Similar trends were observed across a number of other microbial pathogen species [26] . This data in combination with hemotoxicological results forms the basis of an extensive SAR study of the polymers of interest. Figure 5 depicts the measured activity of the eight amine (PA1-8 in green) and eight guanidine (PG1-8 in purple) polymers against S. epidermidis, given as the minimum inhibitory concentrations (MICs). The guanidine poly- 
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Scheme 2 Synthesis of random copolymers containing guanidine side chains.
mers were found to be more potent than their equivalent amine analogues without exception. Figure 6 shows data on the proportion of hemolysis (proportion of lysed human red blood cell) observed at the equivalent concentration to that of the MIC measured with S. epidermidis; this gives an indication of the level of toxicity observed within 'clinically relevant' concentrations. The guanidine series also appeared less hemolytic than the amines in each case. This provides evidence that guanylation leads to an enhancement of activity and a corresponding reduction in toxicity. Note, however, that the degree of change in each case varies somewhat, presumably from the involvement of other aspects of the SAR, to be discussed in the following sections. Figure 7 depicts the antimicrobial activity (MIC values) for the amine and guanidine polymers with similarly matched molecular weights (DP = 17-30) but increasing lipophilic character (MP methyl ). This allows the discrete examination of how overall polymer lipophilicity affects activity. There is a clear trend towards reduced activity with higher methyl content for the amine polymers while there appears to be little to no significant change for the guanidines along the same axis. Previous findings have shown that cationic density appears to be a key factor in determining the activity of other amine-based antimicrobial polymers [4, 8, 30, 31] . This is not surprising given that it is thought to be the cationic charge of polymers that drives the initial interaction with bacterial membranes [2] . The less cationic charge present (high MP methyl ) the less its availability to drive this electrostatic interaction. Why this is different for guanidine-based polymers is not clear at this stage and is to be the subject of future work. However, this difference does suggest a differing mechanism of action for guanidine-rich polymers compared with the amine analogues. Figure 8 depicts the corresponding hemolytic results measured with polymers of differing methyl contents. Almost identical trends were observed across both series, with increasing levels of lipophilicity causing higher levels of toxicity. This is in line with the theory that cationic character is what drives polymer selectivity for bacterial membranes over affinity for human cells. The less cationic charge present, the less selective the polymers are. These findings agree with almost all other studies in the area [4, [32] [33] [34] . These results beg the question as to whether any lipophilic component is necessary for potent and selective antimicrobial activity. The most cationic polymers, PA6 and PG6, (MP methyl = 0) appear to be the most potent and least hemolytic of each series. However, this conclusion is based on data that do not include another important aspect of hemotoxicity, that of hemagglutination. Hemagglutination is the relative ability of polymers to agglutinate or 'clump' red blood cells and can be of concern for many medical applications. Results from these assays revealed that the polymers with the highest level of cationic charge (PA4, PA6 and PG6) also display the highest level of agglutination across the group (moderate to strong levels at the concentrations equivalent to the MIC measured with S. epidermidis). All other polymers were found to exhibit mild to no hemagglutination at equivalent concentrations to their MIC values. Thus, it appears that some level of lipophilic character is necessary if one is to avoid such detrimental effects to human cells while maintaining adequate antimicrobial activity. When all three aspects are considered, it appears that a mid to low range level of lipophilicity (0 % > MP methyl < 44 %) appears optimal to give highly activity antimicrobial polymers that exhibit minimal hemotoxicity. While some others have performed hemagglutination assays on their antimicrobial polymers [35] , this is an assay that has been overlooked by the majority of groups. If this is not considered in combination with MIC and hemolytic data, this can lead to inaccurate conclusions as to the optimal composition to derive safe and effective antimicrobial polymers.
Lipophilicity
Molecular weight
To examine the relationship between molecular weight and antibacterial activity, polymers were selected that had similar levels of overall lipophilicity (MP methyl = 39-51 %) but increasing polymer chain length (DP = 18-174). The trends depicted in Fig. 9 indicate there to be little dependence of activity on molecular weight for amine polymers, while guanidines show a clear reduction in activity with increasing chain length. This again is evidence of there being a fundamental difference between how the amines and guanidines achieve their antimicrobial effects. A potential explanation can be given in light of data obtained from cell penetrating peptides. Here, it has been shown that low molecular weight, arginine-rich peptides are able to quickly translocate across cell membranes while the equivalent lysine-rich peptides show poor uptake [15, 17, 36, 37] . Possibly, at lower molecular weights the guanidine polymers are able to suitably mimic these arginine-rich peptides; diffusing through bacterial membranes to mediate intracellular effects. Furthermore, at the higher molecular weights the surface-mediated mechanisms would start to dominate, approaching a similar level of activity to that observed for the amine series. The possibility of translocation of low MW arginine-rich polymethacrylate polymers across bacterial membranes is a subject of great interest for further study. Polymer chain length also appeared to have a dramatic effect on the measured hemotoxicity of the tested polymers (Fig. 10) . Similar trends were observed for both series, whereby increasing molecular weight gave increasing levels of hemolysis; a result in accord with a number of previous studies [32, 33, 38] .
Identifying the optimal candidate
Thus far, results have shown that choice of cation, lipophilicity and molecular weight appear to be important factors in determining the activity and/or toxicity of the polymers of interest. However, to identify the optimal candidates for human health care applications from this work it becomes necessary to compare both of these aspects in combination. Figure 11 thus depicts an overall matrix for synthesized polymers with a measure of the antimicrobial activity (MIC) on the x-axis and on the y-axis a measure of polymer toxicity (% hemolysis at MIC). This allows the clear differentiation of polymers that show ideal characteristics, namely high activ- ity and low toxicity within the bottom-left quadrant, highlighted in green. Additionally, those polymers that displayed moderate to high hemagglutination at their MIC are represented in blue. Circled in red are the three optimal candidates identified from this study, PG1, PG2 and PG4. These polymers all exhibited high activity against the gram positive bacterium S. epidermidis (MIC = 10-12 μg/mL) and low toxicity towards human red blood cells ( < 4 % hemolysis). These were also among the most potent polymers against the fungal species C. albicans (MIC = 8-32 μg/mL) and against the methicillin-resistant strain of S. aureus (MIC = 94-375 μg/mL), indicating the overlap in SARs for other microbial species. It should be noted that while PG6 displayed similar levels of activity against S. epidermidis and a low percentage of hemolysis similar to that of PG1, PG2 and PG4, it gave a high level of hemagglutination in this additional measure of interaction with human blood. This explains its removal from the 'optimal' category. Hence, it appears that the optimal antimicrobial candidates as indentified from this work correspond to those with guanidines as a cation source, low-molecular-weight (DP < 29), and a low level of lipophilicity (0 % > MP methyl < 44 %).
Conclusions and future directions
Our previous work detailed the synthesis and testing of a series of AMP-mimicking, guanylated polymethacrylates [26] . Eight amine-based random copolymers of MMA and AEMA were prepared and then directly converted into a matched series of eight guanidine p(MMA-co-GEMA) polymers. Each series varied in monomer ratio (lipophilic character) and polymer length to enable systematic investigation of how each of these aspects affects activity and toxicity. Overall, it was found that the guanidine polymers, without exception, showed superior activity against the gram-positive bacterium S. epidermidis and a lower level of human red blood cell toxicity when compared with the corresponding amine polymers. These findings echo similar trends that were observed with Tew's polynorbornenes whereby the replacement of pendant amine groups of an inactive polymer with guanidines gave highly potent species that displayed a low level of hemotoxocity [25] . Hemolysis testing of our polymethacrylates showed similar trends across both the amines and guanidines, with a low level of lipophilicity and low molecular weight favoring a low level of toxicity. Considering antimicrobial activity, lipophilicity appeared to be the dominant factor in determining efficacy for the amine series, while for the guanidines, molecular weight appeared key. These findings highlight a potential difference in the mechanisms underlying the antimicrobial activity of these two classes. Does the molecular weight dependence denote the ability of small guanidine polymers to translocate the cell membrane to mediate their effects intracellularly? Do the amine-based polymers simply interact with the outermost layer of the cell to cause membrane permeabilization and lysis, hence the dependency on lipophilic character? Such hypotheses may also in part supported by the fact that guanidine-based antimicrobial polymers can appear to show bactericidal effects that are not associated with gross-membrane disruption, [25] a behavior that is not observed with the equivalent amine polymers [4] . Future studies will be directed towards elucidating such theories with the antimicrobial polymethacrylates, and may warrant a movement away from the current understanding of the mechanism behind these agents as being dependent simply on membrane permeabilization.
This work also emphasizes the importance of not just attempting to mimic the global cationic and lipophilic qualities of AMPs within synthetic polymers. If we are to truly take inspiration from nature's AMPs to derive effective and safe synthetic antimicrobial polymer therapeutics, one needs to consider the types of amino acids making up these peptides. Each amino acid imparts different pendant functional groups with a unique set of structural, lipophilic and ionic properties. These properties are the key factors determining the potency, selectivity, three-dimensional structure and mechanism of action behind the antimicrobial peptides. The area of AMP-mimicking polymers may hence benefit from the investigation of other monomers that more closely mimic the structural characteristics of specific amino acids which have been identified as important in the activity of AMPs.
The current findings allow the rational optimization of compositional properties to derive a number of ideal candidates from the current series, namely those with guanidines as the cation source, low-molecularweight (DP < 29) and a low level of lipophilicity (0 % > MP methyl < 44 %). PG1, PG2 and PG4 were all found to have high potency (10-12 μg/mL) against S. epidermidis, with little to no observed human cell toxicity at this concentration ( < 4 % hemolysis). This information will not only help to elucidate the SAR governing the antimicrobial polymethacrylates, but may also reveal an important lead for the development of novel therapeutics to combat the growing threat of antibiotic resistance.
